Authors


Richard M. Berlin, MD

Latest:

Otherwise

"All morning I did the work I love. At noon I lay down with my mate. It might have been otherwise."


Richard M. Bloch, PhD

Latest:

Top Papers That Can Change Your Practice

The psychiatric literature is overwhelming. So these authors have culled 25 "top" articles based on their relevance to clinical practice. Here's a quick synopsis of 8 top articles.


Richard Martinez, MD, MH

Latest:

Mini Quiz: Informed Consent

Who wrote the legal opinion that is considered to be the birth of the informed consent doctrine?


Richard Noll, PhD

Latest:

Speak, Memory

In the 1980s, thousands of patients insisted they were recovering childhood memories of physical and sexual abuse during Satanic cult rituals. Here: a look back at the moral panic.


Richard P. Berkson, MD

Latest:

DSM-V: Mind Made Up?

I read with great interest and considerable apprehension Dr. Frances’ assessment of the DSM-V developmental process ("A Warning Sign on the Road to DSM-V," Psychiatric Times, July 2009).


Richard P. Brown, MD

Latest:

Herbal Treatment of Major Depression: Scientific Basis and Practical Use

Many patients can benefit from herbs with gentler action, fewer adverse effects, and some health benefits beyond their antidepressant effects.


Richard P. Kluft, MD, PhD

Latest:

Detecting Sexual Abuse

Few circumstances confront the psychiatrist with more complex, painful, and potentially problematic clinical dilemmas and challenges than the treatment of the incest victim. Here are some factors that may lead to memory of a trauma becoming inaccessible or withheld by a patient.


Richard Rawson, PhD

Latest:

Methamphetamine Abuse: Consequences and Treatment

Methamphetamine (MA) abuse is not a new problem in the United States, but the current epidemic is more widespread and presents with more pernicious consequences than in the past. MA, frequently called "speed," "crystal," "crank," "ice," or "tina," is a potent psychostimulant that can be swallowed in pill form or administered via intranasal, intravenous, or smoking route.


Richard Restak, MD

Latest:

Complex Partial Seizures Present Diagnostic Challenge

Temporal lobe epilepsy (TLE), now more commonly called complexpartial seizure disorder so as to include seizures that originatein the frontal foci, straddles the borderland between psychiatryand neurology.


Richard Ruth, PhD

Latest:

The Rise of Consciousness and the Development of Emotional Life

This volume is written from an emerging edge of basic science and will reward a clinical readership.


Richard S. E. Keefe, PhD

Latest:

Cognitive Impairment in Patients With Bipolar Disorder

It is widely accepted that patients with schizophrenia have some degree of cognitive deficiency and that cognitive deficits are an inherent part of the disorder. Historically, there has been less focus on cognitive deficits in patients with bipolar disorder; however, numerous studies of cognition in patients with bipolar disorder, including several comprehensive meta-analyses of bipolar patients who were euthymic at the time of testing, have recently been undertaken.1-4 Each of these analyses found that cognitive impairment persists during periods of remission, mainly in domains that include attention and processing speed, memory, and executive functioning.4


Richard Shadoan, MD

Latest:

Private Practice Changes: A Personal Perspective

It is amazing how a psychiatric practice changes over the years including the switch to managed care from fee-for-service, larger caseloads, new medications and new treatment options. Despite all the changes, both for better and for worse, one psychiatrist is enjoying his practice as much today as ever before.


Richard Sherer

Latest:

Study Faults Selective Publication of Antidepressant Trials

Medical journals have a unique image in the US health care system. Because most of them adhere to a strict system of critical peer review, they are often seen as unimpeachable sources of accurate information about the safety and efficacy of new medications.


Rick Kam, CIPP/US

Latest:

How to Protect Patient Information

Protecting patient information is an essential part of maintaining patient trust.


Rick Robertson, MD

Latest:

POINT: The Case for Gun Control

Unfortunately, brilliant psychiatrists continue to put on display their ignorance of the Second Amendment and its history.


Ricki Lewis, PhD

Latest:

Cell Phones vs Brain Tumors: Can You Hear Me Now?

brain tumor, neuroma, tumorigenesis, cell phone use


Rieke Oelkers-Ax, MD

Latest:

Headache in Children and Psychiatric Problems

Headache is a frequent somatic complaint in childhood and adolescence, and its prevalence has increased over the last few decades. The presence of a comorbid psychiatric disorder tends to worsen the course of headache by increasing attack frequency and severity, making the headaches less responsive to treatment, and increasing the risk of chronification. Identification and treatment of comorbid psychiatric conditions is, therefore, important for the proper management of headache, especially in children and adolescents.




Rima Styra, MD, MEd

Latest:

Depression and Anxiety in Cardiac Disease

Here: a look at the associations between negative psychological states and CV health, physiologic and health behavior mechanisms, and ways to diagnose and treat depression and anxiety disorders.


Rita Chi-Ying Chung, PhD

Latest:

Southeast Asian Refugees: Gender Difference in Levels and Predictors of Psychological Distress

Among the specialized refugee population in the United States, there is little research on the gender differences in psychological distress, which is considerable. Southeast Asian refugee women have been identified as an at-risk group for developing serious psychiatric disorders primarily due to their premigration experiences.


Rita Hargrave, MD

Latest:

Case Study: Cultural Aspects of Caregiving

This case stresses the importance of identifying cultural issues that arise in mental health clinical encounters.


Riyi Shi, MD, PhD

Latest:

The Role of Acrolein in Spinal Cord Injury

Spinal cord injury, Oxidative stress, Acrolein, Hydralazine


Rob Whitley, PhD

Latest:

Religious Understanding as Cultural Competence: Issues for Clinicians

Improving religious competence among clinicians is vital if everyday psychiatric care is to become truly person-centered.


Robert A. Sweet, MD

Latest:

Taking a New Look at Psychosis in Alzheimer's Disease

Patients with Alzheimer's disease and psychosis often have a more severe course of illness, with higher incidence of caregiver burden and hospitalization. Differentiating this disorder from Alzheimer's disease uncomplicated by psychosis is key to maximizing more positive outcomes.


Robert Boland, MD

Latest:

Reflections on the New Normal

Many physicians thought we could not overestimate the value of having a patient’s full, in-person attention,  nonverbal cues and all. In the current crisis, all of that seems quaint.


Robert C. Baldwin, MD

Latest:

Medical Comorbidities in Late-Life Depression

Late-life depression is both underrecognized and undertreated, and the impact of medical comorbidity may mask depressive symptoms. Depression further complicates the prognosis of medical illness by increasing physical disability and decreasing motivation and adherence to prescribed medications and/or exercise or rehabilitation programs


Robert C. Bransfield, MD

Latest:

Lyme Disease, Comorbid Tick-Borne Diseases, and Neuropsychiatric Disorders

Many recall the phrase "To know syphilis is to know medicine." Now Lyme disease (Lyme borreliosis), the new "great imitator," is the ultimate challenge to the breadth and depth of our knowledge. In psychiatry, we generally treat mental symptoms or syndromes rather than the underlying cause of a disorder.


Robert D. Canning, PhD

Latest:

Depression as Co-Pilot: Clinical Implications of Hepatitis C and Interferon/Ribavirin Treatment

Comorbid substance use disorders may complicate treatment for both the hepatologist and psychiatrist. Comprehensive assessment of psychiatric illness and psychopharmacological management may be critical.


Robert D. Gibbons, PhD

Latest:

The Relationship Between Antidepressant Initiation and Suicide Risk

Ten years ago, the FDA placed a black box warning on all antidepressants because of concerns that the medications increase risk of suicidal thoughts and behavior in youths. It's time for the FDA reevaluate that decision.

© 2025 MJH Life Sciences

All rights reserved.